Login
$PWCM
$0.65 +$0.03 (5.45%) Pre-market

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Cash
Marketable securities
Notes receivable from Seastar Medical Holding Corporation (Note 5)
Less: Allowance for credit loss reserve on notes receivable from Seastar Medical Holding Corporation (Note 5)
Receivable from sale of Symbiont assets (Note 7)
Current portion of notes receivable
Tech Infrastructure JV I LLC
Total current portion of notes receivable
Prepaid expenses and other assets
Finance receivables
Digital assets - current (Note 2)
Digital assets - collateral (Note 2)
Digital assets receivable, net (Note 2)
Galaxy loan derivative asset (Note 4)
Income tax receivable
Current assets
Fixed assets, net (Note 3)
Intangible assets, net (Note 3)
Deposits on mining equipment
Hosting services deposits (Note 4)
Real estate assets owned
Notes receivable net of current portion
SeaStar Medical
Tech Infrastructure JV I LLC
Total notes receivable net of current portion
Long-term investments - equity securities (Note 6)
Investment in Seastar Medical Holding Corporation
Symbiont intangible assets, net (Note 11)
Digital assets - long-term (Note 2)
Operating lease - right of use assets (Note 7)
Right of use assets (Note 5)
Other assets
Long-term assets
Total assets
Liabilities and stockholders' equity
Accounts payable and accrued expenses
Note payable - short-term (Note 4)
Master digital currency loan (Note 4)
Due to related parties (Note 7)
Current portion of lease liability (Note 7)
Galaxy loan derivative liability (Note 6)
Current portion of lease liability (Note 5)
Total current liabilities
Note payable - long-term (Note 4)
Lease liability - net of current portion (Note 7)
Lease liability - net of current portion (Note 5)
Long-term liabilities
Total liabilities
Stockholders' equity (Note 6)
Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, par value $.001; 350,000,000 shares authorized; 934,662 and 564,940 shares issued and outstanding as of June 30, 2026 and December 31, 2025
Additional paid-in capital
Accumulated deficit
Total PowerCompute stockholders' equity
Non-controlling interest
Total stockholders' equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support